C. Diff Recurrence Drops With Highly Targeted Ridinilazole
Phase 3 study results show the highly specific antibiotic was safe and effective and particularly effective in patients not taking another antibiotic.
Source: medscape.com
📰 Summit Pharmaceuticals News
Summit Pharmaceuticals News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Summit Pharmaceuticals. Real-time updates on events, politics, business and more.
CytoReason, Summit tap into AI on drug development effort
The AI technology firm and pharma services company are joining to help one of the country’s leading pharmaceutical firms develop a promising drug candidate.
David Harel Sumitomo Corporation Summit Pharmaceuticals Summit Pharmaceuticals International Preclinical Research Drug Delivery
Source: outsourcing-pharma.com